Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
Danial Mohabati,1,2 Camiel JF Boon,1,3 Suzanne Yzer4 1Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of Ophthalmology, Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands; 3Department of Ophthalmology, Academic Medical Center, University of...
Guardado en:
Autores principales: | Mohabati D, Boon CJF, Yzer S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c68b7b9ab3e43da894bccf034978f79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
por: Ambiya V, et al.
Publicado: (2016) -
Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani S, et al.
Publicado: (2019) -
Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019) -
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati D, et al.
Publicado: (2018) -
Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati D, et al.
Publicado: (2018)